SLC1A5 and non-small cell lung carcinoma: Compared with healthy individuals, early-stage (I and II) NSCLC patients had similar concentrations of SLC1A5 while late-stage treatment naïve patients with EGFR mutation-positive NSCLC had slightly elevated SLC1A5.